Type 2 Diabetes Cases Rising in Young Adults Globally
(MedPage Today) -- The global burden of type 2 diabetes among young people significantly rose since 1990, researchers reported.
Drawing on data from 204 countries and territories, the age-standardized incidence of type 2 diabetes from 1990 to... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 7, 2022 Category: Urology & Nephrology Source Type: news
Should We Change Target Blood Pressure?
(MedPage Today) -- In this exclusive video, Harlan Krumholz, MD, SM, of the Yale School of Medicine and Yale New Haven Hospital in Connecticut, reviews the current research on intensive blood pressure (BP) treatments. He also offers advice on how... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 7, 2022 Category: Urology & Nephrology Source Type: news
Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefit
(MedPage Today) -- Starting heart failure medications before heading home from an acute heart failure hospitalization and rapid up-titration afterward safely improved outcomes across heart failure categories, the STRONG-HF trial showed.
The high... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - November 7, 2022 Category: Urology & Nephrology Source Type: news
Mixed Results With Alerts for AKI-Related Medications in Hospital
(MedPage Today) -- While medication-targeted acute kidney injury (AKI) alerts led to certain kidney-affecting medications being stopped, the overall clinical impact was limited, a researcher reported.
The open-label, randomized trial included... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - November 7, 2022 Category: Urology & Nephrology Source Type: news
Diuretics on Par in Head-to-Head Comparison for Hypertension
(MedPage Today) -- Chlorthalidone didn't best hydrochlorothiazide (HCTZ) for reducing cardiovascular risk in the treatment of hypertension, a pragmatic VA trial showed.
For the primary outcome of major adverse cardiovascular events and non-cancer... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - November 6, 2022 Category: Urology & Nephrology Source Type: news
Not So Cool After All: No CV Benefit with Lower-Temp Dialysate in Hemodialysis
(MedPage Today) -- Using a cooler dialysate during maintenance hemodialysis didn't provide any cardiovascular (CV) benefits, according to the cluster-randomized MyTEMP trial.
In the study of 84 dialysis centers in Ontario, patients receiving a... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - November 6, 2022 Category: Urology & Nephrology Source Type: news
Empagliflozin Protects At-Risk Patients From CKD Progression
(MedPage Today) -- Empagliflozin (Jardiance) reduced the risks of chronic kidney disease (CKD) progression and cardiovascular-related deaths in high-risk patients compared with placebo, the phase III EMPA-KIDNEY trial showed.
Over a median 2-year... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - November 4, 2022 Category: Urology & Nephrology Source Type: news
Lower Entresto Doses Suffice in the Real World
(MedPage Today) -- Heart failure patients unable to reach the target dose of angiotensin receptor/neprilysin inhibitor (ARNI) therapy still reaped gains in health status a year later, according to a post hoc analysis of PROVE-HF.
People taking... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - October 10, 2022 Category: Urology & Nephrology Source Type: news
FDA Approves At-Home Furosemide for Heart Failure
(MedPage Today) -- The FDA approved the first furosemide (Furoscix) formulation for subcutaneous self-administration by patients with congestive heart failure, scPharmaceuticals announced.
The IV-equivalent formulation is indicated for the treatment... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - October 10, 2022 Category: Urology & Nephrology Source Type: news
Low-Fat vs Personalized Diet: Which Is Better for Weight Loss?
(MedPage Today) -- Sticking to a personalized diet focused on a reduction in postprandial glycemic response (PPGR) wasn't any better for weight loss than a run-of-the-mill low-fat diet, the Personal Diet Study found.
Among 204 adults with obesity... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - September 28, 2022 Category: Urology & Nephrology Source Type: news
Hysterectomy: Another Diabetes Risk Factor?
(MedPage Today) -- An early hysterectomy may serve as an independent risk factor for developing future diabetes, according to a French cohort study.
Compared with women with an intact uterus, those who underwent a hysterectomy saw a 20% higher... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - September 22, 2022 Category: Urology & Nephrology Source Type: news
Eye Damage Can Start in Prediabetes
(MedPage Today) -- Elevated blood glucose poses a threat to the eyes even prior to a diabetes diagnosis, according to a Dutch population study.
In cross-sectional data of Maastricht Study participants, a more adverse glucose metabolism status... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - September 22, 2022 Category: Urology & Nephrology Source Type: news
Pulmonary Artery Denervation Improves PAH Symptoms
(MedPage Today) -- BOSTON -- Pulmonary artery denervation improved symptoms in pulmonary arterial hypertension (PAH), a clinical trial from China showed.
The radiofrequency ablation procedure increased 6-minute walk distance by 33.8 m more from... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - September 19, 2022 Category: Urology & Nephrology Source Type: news
Make the Diagnosis: Increased Hair Loss and 'White Bulbs' -- What ’s Up?
(MedPage Today) -- (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - September 14, 2022 Category: Urology & Nephrology Source Type: news
Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yet
(MedPage Today) -- BARCELONA -- For coronary angiography with or without percutaneous coronary intervention (PCI), radial access bested femoral access not only for reduced bleeding, but mortality as well, according to a meta-analysis by the Radial... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - August 29, 2022 Category: Urology & Nephrology Source Type: news
